ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

Dragu R et al. Am J Cardiol 2006; 97:1142-1145.

Therapy Patients, n (%)

Thrombolytic therapy

24 (18.2)

Primary PCI 35 (26.5)

No reperfusion therapy

73 (55.3)

30-day crude mortality by reperfusion strategy Outcome Thrombolysis Primary

PCINo treatment

p

Crude mortality rate (%)

8.3 40.0 29.7 0.03

Dragu R et al. Am J Cardiol 2006; 97:1142-1145.